These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21929364)

  • 1. A TALE of two nucleases: gene targeting for the masses?
    Clark KJ; Voytas DF; Ekker SC
    Zebrafish; 2011 Sep; 8(3):147-9. PubMed ID: 21929364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo genome editing using a high-efficiency TALEN system.
    Bedell VM; Wang Y; Campbell JM; Poshusta TL; Starker CG; Krug RG; Tan W; Penheiter SG; Ma AC; Leung AY; Fahrenkrug SC; Carlson DF; Voytas DF; Clark KJ; Essner JJ; Ekker SC
    Nature; 2012 Nov; 491(7422):114-8. PubMed ID: 23000899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved somatic mutagenesis in zebrafish using transcription activator-like effector nucleases (TALENs).
    Moore FE; Reyon D; Sander JD; Martinez SA; Blackburn JS; Khayter C; Ramirez CL; Joung JK; Langenau DM
    PLoS One; 2012; 7(5):e37877. PubMed ID: 22655075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Origins of Programmable Nucleases for Genome Engineering.
    Chandrasegaran S; Carroll D
    J Mol Biol; 2016 Feb; 428(5 Pt B):963-89. PubMed ID: 26506267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription activator-like effector nucleases (TALENs): a highly efficient and versatile tool for genome editing.
    Sun N; Zhao H
    Biotechnol Bioeng; 2013 Jul; 110(7):1811-21. PubMed ID: 23508559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity.
    Mussolino C; Morbitzer R; Lütge F; Dannemann N; Lahaye T; Cathomen T
    Nucleic Acids Res; 2011 Nov; 39(21):9283-93. PubMed ID: 21813459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FusX: A Rapid One-Step Transcription Activator-Like Effector Assembly System for Genome Science.
    Ma AC; McNulty MS; Poshusta TL; Campbell JM; Martínez-Gálvez G; Argue DP; Lee HB; Urban MD; Bullard CE; Blackburn PR; Man TK; Clark KJ; Ekker SC
    Hum Gene Ther; 2016 Jun; 27(6):451-63. PubMed ID: 26854857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A large-scale in vivo analysis reveals that TALENs are significantly more mutagenic than ZFNs generated using context-dependent assembly.
    Chen S; Oikonomou G; Chiu CN; Niles BJ; Liu J; Lee DA; Antoshechkin I; Prober DA
    Nucleic Acids Res; 2013 Feb; 41(4):2769-78. PubMed ID: 23303782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and application of site-specific artificial nucleases for targeted gene editing.
    Kok FO; Gupta A; Lawson ND; Wolfe SA
    Methods Mol Biol; 2014; 1101():267-303. PubMed ID: 24233786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput genome editing and phenotyping facilitated by high resolution melting curve analysis.
    Thomas HR; Percival SM; Yoder BK; Parant JM
    PLoS One; 2014; 9(12):e114632. PubMed ID: 25503746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TALEN-Mediated Mutagenesis and Genome Editing.
    Ma AC; Chen Y; Blackburn PR; Ekker SC
    Methods Mol Biol; 2016; 1451():17-30. PubMed ID: 27464798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid mutation of endogenous zebrafish genes using zinc finger nucleases made by Oligomerized Pool ENgineering (OPEN).
    Foley JE; Yeh JR; Maeder ML; Reyon D; Sander JD; Peterson RT; Joung JK
    PLoS One; 2009; 4(2):e4348. PubMed ID: 19198653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering customized TALE nucleases (TALENs) and TALE transcription factors by fast ligation-based automatable solid-phase high-throughput (FLASH) assembly.
    Reyon D; Maeder ML; Khayter C; Tsai SQ; Foley JE; Sander JD; Joung JK
    Curr Protoc Mol Biol; 2013 Jul; Chapter 12():Unit 12.16. PubMed ID: 23821439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [TALE nuclease engineering and targeted genome modification].
    Shen Y; Xiao A; Huang P; Wang WY; Zhu ZY; Zhang B
    Yi Chuan; 2013 Apr; 35(4):395-409. PubMed ID: 23659930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for targeted mutagenesis in zebrafish using TALENs.
    Hwang WY; Peterson RT; Yeh JR
    Methods; 2014 Aug; 69(1):76-84. PubMed ID: 24747922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion of homologous DNA in nuclease-mediated gene targeting facilitates a higher incidence of bi-allelically modified cells.
    Beaton BP; Kwon DN; Choi YJ; Kim JH; Samuel MS; Benne JA; Wells KD; Lee K; Kim JH; Prather RS
    Xenotransplantation; 2015; 22(5):379-90. PubMed ID: 26381494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparison of ZFNs, TALENs, and SpCas9 by GUIDE-seq in HPV-targeted gene therapy.
    Cui Z; Liu H; Zhang H; Huang Z; Tian R; Li L; Fan W; Chen Y; Chen L; Zhang S; Das BC; Severinov K; Hitzeroth II; Debata PR; Jin Z; Liu J; Huang Z; Xie W; Xie H; Lang B; Ma J; Weng H; Tian X; Hu Z
    Mol Ther Nucleic Acids; 2021 Dec; 26():1466-1478. PubMed ID: 34938601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded activity of dimer nucleases by combining ZFN and TALEN for genome editing.
    Yan W; Smith C; Cheng L
    Sci Rep; 2013; 3():2376. PubMed ID: 23921522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of Alternative Nucleases in the Age of CRISPR/Cas9.
    Guha TK; Edgell DR
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome editing of oncogenes with ZFNs and TALENs: caveats in nuclease design.
    Shankar S; Sreekumar A; Prasad D; Das AV; Pillai MR
    Cancer Cell Int; 2018; 18():169. PubMed ID: 30386178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.